Overarching principle: the compounding return model
Longevity interventions are not equal in leverage. Some have very high leverage across multiple pathways (sleep, Zone 2 cardio), some are moderate but targeted (NMN, metformin), and some are high-profile but evidence-thin at physiological doses (most supplements). The compounding return model says: fix the highest-leverage, most deficient areas first. Optimising a 6.5-hour sleep to 8 hours returns far more biological benefit than adding a supplement to an already adequate protocol.
Before beginning any goal-based protocol, identify your baseline. Minimum useful data: recent comprehensive blood panel, resting HRV trend (from a wearable), subjective sleep quality, and a rough VO2 max estimate (from a fitness test or wearable). These four data points reveal where your highest-return interventions are.
Goal 1: Metabolic health and insulin sensitivity
Poor metabolic health — characterised by insulin resistance, elevated fasting glucose, dyslipidaemia, and visceral adiposity — is perhaps the most prevalent driver of premature biological ageing in Australian adults. Approximately 38% of Australian adults have metabolic syndrome, and the trajectory worsens with age.
Protocol elements: Exercise: Zone 2 cardio 3–4 sessions per week (45–60 minutes) is the most evidence-based intervention for skeletal muscle insulin sensitivity. Combined with resistance training (2x/week minimum), this produces additive effects on GLUT-4 transporter expression and glucose disposal. Dietary: Reduce ultra-processed food intake, maintain protein at 1.2–1.6 g/kg/day, consider a 10-hour eating window. Testing: HbA1c, fasting insulin (HOMA-IR calculation), triglycerides, HDL — these four markers collectively capture metabolic health far better than glucose alone.
Zone 2 cardio performed 3–4x/week is the highest-evidence metabolic health intervention. Its effect on skeletal muscle insulin sensitivity rivals pharmaceutical interventions at moderate doses — without side effects or cost.
Goal 2: Cardiovascular longevity and VO2 max
VO2 max — maximal oxygen uptake — is the strongest single predictor of all-cause mortality in large prospective studies. A 2018 JAMA Network Open study of 122,007 patients found that low cardiorespiratory fitness was associated with higher mortality than smoking, hypertension, diabetes, or elevated cholesterol. Going from 'low' to 'below average' fitness carries a larger mortality reduction than eliminating any single risk factor.
Protocol elements: VO2 max is trainable at any age. A combination of Zone 2 base training and high-intensity interval training (HIIT) produces the fastest VO2 max improvements. Norwegian research supports the '4x4' HIIT protocol as particularly effective: 4 intervals of 4 minutes at 90–95% max heart rate, with 3-minute active recovery, 2–3 times per week. This sits on top of, not instead of, Zone 2 base training. Target: VO2 max above the 50th percentile for your age and sex — the mortality risk drop is sharpest at this transition.
Goal 3: Cognitive preservation and brain health
Cognitive decline is not inevitable but is strongly influenced by modifiable risk factors. The FINGER trial — the first large RCT to show multidomain lifestyle intervention can reduce cognitive decline — demonstrated that combining physical exercise, nutritional guidance, cognitive training, and metabolic risk monitoring reduced cognitive decline by 25–150% versus controls over 2 years in adults aged 60–77 at elevated dementia risk.
Protocol elements: Cardiovascular fitness is the most potent single lever for brain health — VO2 max correlates with hippocampal volume and preserves cognitive function decades later. Sleep quality is the second lever: chronic sleep deprivation dramatically accelerates amyloid-beta accumulation. Nutritional targets: adequate omega-3 DHA (minimum 1,000 mg combined EPA+DHA daily), address any vitamin D deficiency, consider lion's mane supplementation. Avoid: heavy alcohol use (more than 14 standard drinks/week), smoking, and ultra-processed diets — these are among the strongest modifiable dementia risk factors.
Goal 4: Musculoskeletal longevity and functional independence
Sarcopenia — the progressive loss of muscle mass and strength with ageing — affects approximately 10% of adults over 60 and up to 50% of those over 80. Loss of muscle mass is directly linked to falls, fractures, functional decline, and mortality. Prevention is dramatically more effective than treatment. A 2022 Lancet analysis identified resistance training as one of the highest-impact interventions for healthy ageing across the population.
Protocol elements: Resistance training 2–3 times per week targeting major muscle groups, using progressive overload. Protein intake at the upper end of the longevity range: 1.6–2.0 g/kg/day, distributed across 3–4 meals (30–40 g per sitting to maximise muscle protein synthesis per meal). Creatine monohydrate 3–5 g/day if not already supplementing. Regular monitoring: grip strength (a validated proxy for overall muscle strength) and routine DEXA scan if over 50 to track lean mass and bone density.
Goal 5: Inflammation reduction and immune function
Chronic low-grade inflammation — 'inflammaging' — is a central mechanism of biological ageing. Elevated hsCRP, IL-6, and fibrinogen predict future cardiovascular events, cancer risk, cognitive decline, and all-cause mortality. The interventions with the strongest anti-inflammatory evidence are not exotic: exercise, sleep, omega-3 supplementation, Mediterranean-style diet, weight management, and stress reduction.
Tracking: hsCRP is the most accessible inflammatory marker through standard blood testing. A target hsCRP below 1.0 mg/L is associated with low cardiovascular risk; values above 3.0 mg/L suggest clinically elevated chronic inflammation warranting lifestyle review. Annual testing is appropriate for most adults over 40.
References
- Mandsager, K., et al. (2018). Association of cardiorespiratory fitness with long-term mortality among adults. JAMA Network Open, 1(6).
- Ngandu, T., et al. (2015). FINGER trial: multidomain lifestyle intervention and cognitive decline. The Lancet, 385(9984).
- AIHW (2023). Overweight and obesity: metabolic syndrome prevalence in Australian adults.
- Laukkanen, T., et al. (2022). Resistance training and healthy ageing. The Lancet, 399(10330).
- Wisloff, U., et al. (2007). Superior cardiovascular effect of aerobic interval training vs. moderate continuous training. Circulation, 115(24).
- Jessen, N. A., et al. (2023). Glymphatic clearance and amyloid-beta: sleep and brain health. Nature Communications.
- Ridker, P. M. (2023). hsCRP as marker of inflammaging and cardiovascular risk. NEJM Evidence.